Exclusive-Germany's Merck KGaA in talks to buy US cancer biotech firm Springworks, sources say
Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases drugmaker Springworks Therapeutics , according to people familiar with the matter.
Merck KGaA in advanced talks to acquire SpringWorks Therapeutics, Reuters says
German healthcare and technology group Merck KGaA (MKGAY) is in advanced talks to acquire U.S. cancer and rare disease drugmaker Springworks ...